Olivier Mathieu/LinkedIn
Jul 9, 2026, 13:16
Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
Olivier Mathieu, Manager at Stago, shared a post on LinkedIn:
”Tomorrow’s routine assays were yesterday’s crazy ideas.
At isth2026, our Prospective Research Department team will be pleased to share concepts of new assays at the Stago scientific lounge.
Honored to showcase the work of an outstanding multidisciplinary team pushing innovation from early scientific ideas to future clinical applications to the benefit for patients.
Looking forward to engaging with the scientific community and bridging innovation with real-world needs in hemostasis.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE
-
Oct 12, 2026, 20:43Jazlyn A Selvasingh: Excited to Share Our Research at AAO-HNSF 2026 in Los Angeles
-
Oct 12, 2026, 20:31Natalia Kovtun: Higher Ferritin Cutoffs Now Define Iron Deficiency
-
Oct 12, 2026, 19:39Edward Loftus: Using Low-Dose Aspirin in Pregnant Women With IBD
-
Oct 12, 2026, 19:32Shruti Sachdeva: Strengthening the Fight against Anemia